Clinical trial No longer in our active list Observational Ages 18 to 60

Understanding the effects of ultramarathon running on athletes

Official title: Penyagolosa Trail Saludable 2025

Run by Universitat Jaume I · NCT06969898 · Data updated 2026-05-14

This study is no longer in our active list. It may have stopped recruiting or finished. The details below are as of 2026-05-14 and are kept for reference. Check ClinicalTrials.gov for its current status, or see similar studies below.

This study looks at how running a long ultramarathon affects athletes' training, health, and recovery to see what factors influence their performance and if there are differences between men and women.

More Physical Exercise trials

Quick facts

Study typeObservational
Ages18 Years to 60 Years
SexAll
Enrollment50 (estimated)
SponsorUniversitat Jaume I
Academic / other
Locations1 site (Castellón De La Plana, Castellón)
Trial IDNCT06969898 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are healthy adults aged 18-60 who have completed at least two races of 65 km or longer and are registered for the CSP 2025 race.

Probably not a fit

Patients with heart or kidney disease, or those taking ongoing medications, may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study focuses on Ultratrail runners participating in the 106 km Castelló-Penyagolosa race, aiming to gather insights into their training habits, physical condition, and performance factors. The research involves data collection before, during, and after the race, including assessments of muscle damage, strength loss, and hydration levels. Blood and urine samples will be analyzed to track physiological changes and recovery processes. Additionally, the study will explore sex differences in performance and physiological responses among the runners.

Why it matters

Potential benefit: If successful, this study could enhance understanding of ultramarathon running and improve training and recovery strategies for athletes.

How similar studies have gone: While there is growing interest in the physiological impacts of ultramarathon events, this specific approach to studying athletes during the race is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Adults healthy with 18-60 years
* Must have completed at least two races of 65 km or longer.
* Must be registered as a participant in the CSP 2025 race

Exclusion Criteria:

* Having heart disease
* Having kidney disease
* Taking a medication on an ongoing basis

Where it's running

  • Jaume I Univesity
    Castellón De La Plana, Castellón, Spain
    Recruiting

Study contacts

  • Principal investigator: Carlos Hernando — Universitat Jaume I
  • Study coordinator: Carlos Hernando, Dr.
  • Email: hernando@uji.es
  • Phone: +034964728808

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.